We therefore hypothesize that identifying parameters reflecting both tumor characteristics and host SIR may be a better approach for predicting patient survival, and COCN (combination of CEA and NLR) may be a better biomarker in the prognostic assessment of CRC. This evidence concerns the gene CEACAM5 and colorectal carcinoma.